Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Klimentini E Karageorgiou"'
Autor:
Konstantina Sykara, Michalis Mougias, Evdoxia Mavragani, Klimentini E Karageorgiou, Hara Tsekou, Elissaios Karageorgiou, Jeronimo Martin Ramirez, Nikolaos Andronas
Publikováno v:
Alzheimer's & Dementia. 16
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c004eef4c56fa37bd4f46308e54e0a12
https://doi.org/10.1002/alz.047634
https://doi.org/10.1002/alz.047634
Autor:
Klimentini E Karageorgiou, Hara Tsekou, Konstantina Sykara, Jeronimo Martin Ramirez, Michalis Mougias, Nikolaos Andronas, Evdoxia Mavragani, Elissaios Karageorgiou
Publikováno v:
Alzheimer's & Dementia. 16
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c6f46e9d3222bdb4e7f5b0c08be3b66b
https://doi.org/10.1002/alz.047564
https://doi.org/10.1002/alz.047564
Autor:
Dimos D. Mitsikostas, Vassiliki A. Fili, Klimentini E. Karageorgiou, Anna Siatouni, Theodore G. Avramidis, George V. Pantes, Stylianos Gatzonis, Pantelis Stathis, Michail Vikelis
Publikováno v:
Headache: The Journal of Head and Face Pain. 50:1371-1377
Objective.— To explore the efficacy and tolerability of levetiracetam in medical treatment of trigeminal neuralgia. Background.— Antiepileptic drugs (AEDs) are considered as first-line treatment for trigeminal neuralgia, although their use is oft
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ab02091572ab2397b870503c83cfa6c1
https://doi.org/10.1111/j.1526-4610.2010.01743.x
https://doi.org/10.1111/j.1526-4610.2010.01743.x
Autor:
Dimos D, Mitsikostas, George V, Pantes, Theodore G, Avramidis, Klimentini E, Karageorgiou, Stylianos D, Gatzonis, Pantelis G, Stathis, Vassiliki A, Fili, Anna D, Siatouni, Michail, Vikelis
Publikováno v:
Headache. 50(8)
To explore the efficacy and tolerability of levetiracetam in medical treatment of trigeminal neuralgia.Antiepileptic drugs (AEDs) are considered as first-line treatment for trigeminal neuralgia, although their use is often limited due to incomplete e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f8727d4c7297babb995b1123dd6815a0
https://pubmed.ncbi.nlm.nih.gov/21044281
https://pubmed.ncbi.nlm.nih.gov/21044281
Autor:
Jette L. Frederiksen, Miguel A. Macías Islas, Astrid Edland, Tjalf Ziemssen, João Correia de Sá, Nina de Klippel, Adriana Carrá, Yossi Gilgun-Sherki, Klimentini E. Karageorgiou, Niall Tubridy, Olivier Heinzlef, Rafael H. Lander Delgado, Ovidiu Bajenaru, Anne-Marie Landtblom
Publikováno v:
Journal of Neurology
Studies suggest that patients with relapsing-remitting multiple sclerosis (RRMS) who do not benefit from other disease-modifying treatments (DMTs) may benefit from converting to glatiramer acetate (GA). COPTIMIZE was a 24-month observational study de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a19c262198d3426ea075e20fdf1db9c2
http://europepmc.org/articles/PMC4643571
http://europepmc.org/articles/PMC4643571